Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
thioredoxin reductase | 23 | 0 | 0 | 23 |
USP1 protein, partial | 14 | 0 | 0 | 14 |
TDP1 protein | 31 | 0 | 0 | 31 |
vitamin D3 receptor isoform VDRA | 19 | 0 | 0 | 19 |
importin subunit beta-1 isoform 1 | 3 | 0 | 0 | 3 |
flap endonuclease 1 | 10 | 0 | 0 | 10 |
serine/threonine-protein kinase PLK1 | 5 | 0 | 0 | 5 |
snurportin-1 | 3 | 0 | 0 | 3 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 7 | 0 | 0 | 7 |
GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase eta isoform 1 | 5 | 0 | 0 | 5 |
DNA polymerase iota isoform a (long) | 9 | 0 | 0 | 9 |
urokinase-type plasminogen activator precursor | 8 | 0 | 0 | 8 |
plasminogen precursor | 8 | 0 | 0 | 8 |
urokinase plasminogen activator surface receptor precursor | 8 | 0 | 0 | 8 |
geminin | 30 | 0 | 0 | 30 |
DNA polymerase kappa isoform 1 | 10 | 0 | 0 | 10 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Transthyretin | 0 | 0 | 1 | 1 |
Fatty acid-binding protein, intestinal | 0 | 1 | 1 | 2 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Choline O-acetyltransferase | 0 | 2 | 0 | 2 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 11 | 0 | 0 | 11 |
RAR-related orphan receptor gamma | 28 | 0 | 0 | 28 |
GLI family zinc finger 3 | 31 | 0 | 0 | 31 |
AR protein | 40 | 0 | 0 | 40 |
aldehyde dehydrogenase 1 family, member A1 | 26 | 0 | 0 | 26 |
retinoic acid nuclear receptor alpha variant 1 | 29 | 0 | 0 | 29 |
retinoid X nuclear receptor alpha | 20 | 0 | 0 | 20 |
estrogen nuclear receptor alpha | 42 | 0 | 0 | 42 |
peroxisome proliferator-activated receptor delta | 20 | 0 | 0 | 20 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 18 | 0 | 0 | 18 |
activating transcription factor 6 | 10 | 0 | 0 | 10 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 13 | 0 | 0 | 13 |
Histone H2A.x | 11 | 0 | 0 | 11 |
thyroid hormone receptor beta isoform a | 14 | 0 | 0 | 14 |
heat shock protein beta-1 | 10 | 0 | 0 | 10 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 31 | 0 | 0 | 31 |
lamin isoform A-delta10 | 23 | 0 | 0 | 23 |
Voltage-dependent calcium channel gamma-2 subunit | 13 | 0 | 0 | 13 |
Glutamate receptor 2 | 13 | 0 | 0 | 13 |
Luciferase | 13 | 0 | 0 | 13 |
pregnane X receptor | 11 | 0 | 0 | 11 |
phosphopantetheinyl transferase | 14 | 0 | 0 | 14 |
SMAD family member 2 | 10 | 0 | 0 | 10 |
SMAD family member 3 | 10 | 0 | 0 | 10 |
Microtubule-associated protein tau | 15 | 0 | 0 | 16 |
caspase 7, apoptosis-related cysteine protease | 4 | 0 | 0 | 4 |
nuclear receptor subfamily 1, group I, member 3 | 23 | 0 | 0 | 23 |
estrogen-related nuclear receptor alpha | 30 | 0 | 0 | 30 |
farnesoid X nuclear receptor | 17 | 0 | 0 | 17 |
pregnane X nuclear receptor | 24 | 0 | 0 | 24 |
peroxisome proliferator activated receptor gamma | 18 | 0 | 0 | 18 |
caspase-3 | 4 | 0 | 0 | 4 |
euchromatic histone-lysine N-methyltransferase 2 | 31 | 0 | 0 | 31 |
aryl hydrocarbon receptor | 14 | 0 | 0 | 14 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 7 | 0 | 0 | 7 |
Cellular tumor antigen p53 | 28 | 0 | 0 | 28 |
Cytochrome P450 1A2 | 0 | 4 | 2 | 6 |
Tyrosine-protein kinase Lck | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 7 | 0 | 7 |
Adenosine receptor A3 | 0 | 8 | 0 | 8 |
Alpha-1B adrenergic receptor | 0 | 11 | 0 | 11 |
Acetylcholinesterase | 0 | 5 | 0 | 5 |
Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
Aryl hydrocarbon receptor | 0 | 0 | 1 | 1 |
Alpha-1A adrenergic receptor | 0 | 12 | 0 | 12 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 5 |
Chain A, 2-oxoglutarate Oxygenase | 15 | 0 | 0 | 15 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 8 | 0 | 0 | 8 |
acetylcholinesterase | 9 | 0 | 0 | 9 |
dopamine D1 receptor | 3 | 0 | 0 | 3 |
15-lipoxygenase, partial | 7 | 0 | 0 | 7 |
NFKB1 protein, partial | 5 | 0 | 0 | 5 |
Thrombopoietin | 5 | 0 | 0 | 5 |
regulator of G-protein signaling 4 | 14 | 0 | 0 | 14 |
glucocorticoid receptor [Homo sapiens] | 25 | 0 | 0 | 25 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 18 | 0 | 0 | 18 |
arylsulfatase A | 8 | 0 | 0 | 8 |
Bloom syndrome protein isoform 1 | 12 | 0 | 0 | 12 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
thyroid hormone receptor beta isoform 2 | 24 | 0 | 0 | 24 |
peripheral myelin protein 22 | 14 | 0 | 0 | 14 |
survival motor neuron protein isoform d | 9 | 0 | 0 | 9 |
muscarinic acetylcholine receptor M1 | 9 | 0 | 0 | 9 |
Histone deacetylase 3 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 6 | 0 | 6 |
Histone deacetylase 4 | 0 | 2 | 0 | 2 |
Histone deacetylase 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 7 | 0 | 2 | 0 | 2 |
Histone deacetylase 2 | 0 | 2 | 0 | 2 |
Polyamine deacetylase HDAC10 | 0 | 2 | 0 | 2 |
Histone deacetylase 11 | 0 | 2 | 0 | 2 |
Ataxin-2 | 9 | 0 | 0 | 9 |
Histone deacetylase 8 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 2 | 0 | 2 |
Histone deacetylase 9 | 0 | 2 | 0 | 2 |
Histone deacetylase 5 | 0 | 2 | 0 | 2 |
ATP-dependent phosphofructokinase | 15 | 0 | 0 | 15 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 13 | 0 | 0 | 13 |
Chain A, Beta-lactamase | 9 | 0 | 0 | 9 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 4 |
apical membrane antigen 1, AMA1 | 4 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 2 |
ATP-binding cassette sub-family C member 3 | 0 | 22 | 0 | 22 |
Multidrug resistance-associated protein 4 | 0 | 22 | 0 | 24 |
Bile salt export pump | 0 | 5 | 0 | 5 |
Bile salt export pump | 0 | 34 | 0 | 34 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 2 |
Beta-lactamase SHV-1 | 0 | 0 | 0 | 4 |
Cytochrome P450 2C9 | 0 | 4 | 1 | 5 |
Beta-lactamase | 0 | 0 | 0 | 5 |
Kappa-type opioid receptor | 0 | 0 | 0 | 3 |
Solute carrier family 15 member 1 | 0 | 6 | 0 | 6 |
Solute carrier family 15 member 1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 5 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Solute carrier family 15 member 2 | 0 | 3 | 0 | 3 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Canalicular multispecific organic anion transporter 1 | 0 | 19 | 0 | 19 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Chain A, Cruzipain | 9 | 0 | 0 | 9 |
Beta-lactamase | 0 | 2 | 0 | 4 |
GLS protein | 12 | 0 | 0 | 12 |
Beta-lactamase | 0 | 2 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Metallo-beta-lactamase type 2 | 0 | 0 | 1 | 6 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 5 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Metallo-beta-lactamase | 0 | 0 | 0 | 5 |
Beta-lactamase | 0 | 2 | 0 | 4 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 11 | 0 | 0 | 11 |
chromobox protein homolog 1 | 18 | 0 | 0 | 18 |
DNA polymerase beta | 3 | 0 | 0 | 3 |
Carbonic anhydrase 1 | 0 | 11 | 0 | 14 |
Carbonic anhydrase 2 | 0 | 11 | 1 | 15 |
60 kDa heat shock protein, mitochondrial | 0 | 5 | 0 | 5 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 3 |
Spike glycoprotein | 11 | 2 | 2 | 15 |
10 kDa heat shock protein, mitochondrial | 0 | 5 | 0 | 5 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 4 |
Thiosulfate sulfurtransferase | 0 | 5 | 0 | 5 |
Metallo-beta-lactamase VIM-13 | 0 | 1 | 0 | 5 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 5 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 2 |
60 kDa chaperonin | 0 | 5 | 0 | 5 |
Metallo-beta-lactamase | 0 | 0 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 5 |
Beta-lactamase | 0 | 0 | 1 | 4 |
10 kDa chaperonin | 0 | 5 | 0 | 5 |
Metallo-b-lactamase | 0 | 0 | 0 | 7 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 5 |
Histamine H3 receptor | 0 | 0 | 0 | 5 |
Beta-lactamase class B VIM-2 | 0 | 0 | 1 | 8 |
Beta-lactamase VIM-1 | 0 | 1 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 14 | 0 | 0 | 14 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 10 | 0 | 0 | 10 |
Chain B, HADH2 protein | 10 | 0 | 0 | 10 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 8 | 0 | 0 | 8 |
thyroid stimulating hormone receptor | 17 | 0 | 0 | 17 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 16 | 0 | 0 | 16 |
EWS/FLI fusion protein | 15 | 0 | 0 | 15 |
cytochrome P450 2D6 | 10 | 0 | 0 | 10 |
glucocerebrosidase | 3 | 0 | 0 | 3 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 7 | 0 | 0 | 7 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
lethal factor (plasmid) | 8 | 0 | 0 | 8 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Epidermal growth factor receptor | 0 | 6 | 0 | 6 |
Fatty acid-binding protein, liver | 0 | 2 | 0 | 2 |
Integrin beta-3 | 4 | 1 | 0 | 5 |
Myeloperoxidase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 4 | 1 | 0 | 5 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Adenosine receptor A1 | 0 | 1 | 0 | 2 |
Adenosine receptor A2a | 0 | 1 | 0 | 2 |
Substance-P receptor | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 5 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 9 | 1 | 2 | 12 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 12 | 8 | 2 | 22 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 5 | 0 | 5 |
Solute carrier family 22 member 6 | 0 | 5 | 0 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 1 | 6 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
progesterone receptor | 13 | 0 | 0 | 13 |
nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 5 | 0 | 0 | 5 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 6 | 1 | 7 |
Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
ORF73 | 0 | 0 | 1 | 1 |
thyroid stimulating hormone receptor | 14 | 0 | 0 | 14 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 3 |
potassium voltage-gated channel subfamily H member 2 isoform d | 8 | 0 | 0 | 8 |
Cytochrome P450 2E1 | 0 | 1 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 5 | 0 | 0 | 5 |
Smad3 | 3 | 0 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 5 |
Solute carrier family 22 member 8 | 0 | 3 | 0 | 6 |
Solute carrier family 22 member 11 | 0 | 2 | 0 | 5 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Metallo-beta-lactamase VIM-19 | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Albumin | 0 | 2 | 5 | 8 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 4 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 4 |
BlaVIM-1 | 0 | 0 | 0 | 4 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 4 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 2 |
G | 9 | 0 | 0 | 9 |
streptokinase A precursor | 0 | 0 | 5 | 5 |
Interferon beta | 10 | 0 | 0 | 10 |
HLA class I histocompatibility antigen, B alpha chain | 9 | 0 | 0 | 9 |
30S ribosomal protein S6 | 0 | 4 | 1 | 5 |
30S ribosomal protein S7 | 0 | 4 | 1 | 5 |
50S ribosomal protein L15 | 0 | 4 | 1 | 5 |
Cytochrome P450 3A4 | 0 | 7 | 2 | 9 |
50S ribosomal protein L10 | 0 | 4 | 1 | 5 |
50S ribosomal protein L11 | 0 | 4 | 1 | 5 |
50S ribosomal protein L7/L12 | 0 | 4 | 1 | 5 |
50S ribosomal protein L19 | 0 | 4 | 1 | 5 |
50S ribosomal protein L1 | 0 | 4 | 1 | 5 |
50S ribosomal protein L20 | 0 | 4 | 1 | 5 |
50S ribosomal protein L27 | 0 | 4 | 1 | 5 |
50S ribosomal protein L28 | 0 | 4 | 1 | 5 |
50S ribosomal protein L29 | 0 | 4 | 1 | 5 |
50S ribosomal protein L31 | 0 | 4 | 1 | 5 |
50S ribosomal protein L31 type B | 0 | 4 | 1 | 5 |
50S ribosomal protein L32 | 0 | 4 | 1 | 5 |
50S ribosomal protein L33 | 0 | 4 | 1 | 5 |
50S ribosomal protein L34 | 0 | 4 | 1 | 5 |
50S ribosomal protein L35 | 0 | 4 | 1 | 5 |
50S ribosomal protein L36 | 0 | 4 | 1 | 5 |
30S ribosomal protein S10 | 0 | 4 | 1 | 5 |
30S ribosomal protein S11 | 0 | 4 | 1 | 5 |
30S ribosomal protein S12 | 0 | 4 | 1 | 5 |
30S ribosomal protein S13 | 0 | 4 | 1 | 5 |
30S ribosomal protein S16 | 0 | 4 | 1 | 5 |
30S ribosomal protein S18 | 0 | 4 | 1 | 5 |
30S ribosomal protein S19 | 0 | 4 | 1 | 5 |
30S ribosomal protein S20 | 0 | 4 | 1 | 5 |
30S ribosomal protein S2 | 0 | 4 | 1 | 5 |
30S ribosomal protein S3 | 0 | 4 | 1 | 5 |
30S ribosomal protein S4 | 0 | 4 | 1 | 5 |
30S ribosomal protein S5 | 0 | 4 | 1 | 5 |
30S ribosomal protein S8 | 0 | 4 | 1 | 5 |
30S ribosomal protein S9 | 0 | 4 | 1 | 5 |
50S ribosomal protein L13 | 0 | 4 | 1 | 5 |
50S ribosomal protein L14 | 0 | 4 | 1 | 5 |
50S ribosomal protein L16 | 0 | 4 | 1 | 5 |
50S ribosomal protein L23 | 0 | 4 | 1 | 5 |
30S ribosomal protein S15 | 0 | 4 | 1 | 5 |
50S ribosomal protein L17 | 0 | 4 | 1 | 5 |
50S ribosomal protein L21 | 0 | 4 | 1 | 5 |
50S ribosomal protein L30 | 0 | 4 | 1 | 5 |
50S ribosomal protein L6 | 0 | 4 | 1 | 5 |
30S ribosomal protein S14 | 0 | 4 | 1 | 5 |
30S ribosomal protein S17 | 0 | 4 | 1 | 5 |
30S ribosomal protein S1 | 0 | 4 | 1 | 5 |
50S ribosomal protein L18 | 0 | 4 | 1 | 5 |
50S ribosomal protein L2 | 0 | 4 | 1 | 5 |
50S ribosomal protein L3 | 0 | 4 | 1 | 5 |
50S ribosomal protein L24 | 0 | 4 | 1 | 5 |
50S ribosomal protein L4 | 0 | 4 | 1 | 5 |
50S ribosomal protein L22 | 0 | 4 | 1 | 5 |
50S ribosomal protein L5 | 0 | 4 | 1 | 5 |
30S ribosomal protein S21 | 0 | 4 | 1 | 5 |
50S ribosomal protein L25 | 0 | 4 | 1 | 5 |
50S ribosomal protein L36 2 | 0 | 4 | 1 | 5 |
Inositol hexakisphosphate kinase 1 | 9 | 0 | 0 | 9 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 9 | 0 | 0 | 9 |
Proteasome subunit beta type-11 | 0 | 0 | 0 | 1 |
ATAD5 protein, partial | 10 | 0 | 0 | 10 |
Fumarate hydratase | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 13 | 0 | 0 | 13 |
NADPH oxidase 1 | 0 | 1 | 0 | 1 |
polyprotein | 4 | 0 | 0 | 4 |
67.9K protein | 4 | 0 | 0 | 4 |
Snq2p | 0 | 0 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 2 | 0 | 2 |
Caspase-7 | 4 | 0 | 0 | 4 |
Spike glycoprotein | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
cellular tumor antigen p53 isoform a | 4 | 0 | 0 | 4 |
caspase-3 | 4 | 0 | 0 | 4 |
histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
mitogen-activated protein kinase 1 | 9 | 0 | 0 | 9 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
cytochrome P450 3A4 isoform 1 | 12 | 0 | 0 | 12 |
M-phase phosphoprotein 8 | 8 | 0 | 0 | 8 |
histone acetyltransferase KAT2A isoform 1 | 12 | 0 | 0 | 12 |
Gamma-aminobutyric acid receptor subunit pi | 12 | 7 | 1 | 20 |
Proteasome subunit alpha type-7 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 3 | 0 | 6 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 7 | 0 | 0 | 7 |
Transmembrane protease serine 2 | 0 | 2 | 2 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Albumin | 0 | 0 | 2 | 2 |
Major prion protein | 0 | 0 | 2 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 0 | 1 | 1 |
Procathepsin L | 0 | 2 | 2 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 8 | 0 | 8 |
Muscarinic acetylcholine receptor M4 | 0 | 8 | 0 | 8 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 3 | 1 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 3 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 3 |
Muscarinic acetylcholine receptor M5 | 0 | 7 | 0 | 7 |
Alpha-2A adrenergic receptor | 0 | 6 | 0 | 6 |
Replicase polyprotein 1a | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Cys-loop ligand-gated ion channel | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 3 | 1 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Cytochrome P450 2D6 | 0 | 5 | 2 | 7 |
Muscarinic acetylcholine receptor M2 | 0 | 3 | 2 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 8 | 0 | 8 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 6 | 0 | 7 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 12 | 7 | 1 | 20 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Alpha-2B adrenergic receptor | 0 | 8 | 0 | 8 |
Gamma-aminobutyric acid receptor subunit delta | 12 | 7 | 1 | 20 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 12 | 7 | 2 | 21 |
Alpha-2C adrenergic receptor | 0 | 6 | 0 | 6 |
D | 0 | 2 | 0 | 2 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 8 | 1 | 9 |
Alpha-2B adrenergic receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 12 | 7 | 1 | 20 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 12 | 7 | 1 | 20 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 7 | 0 | 7 |
Proteasome subunit beta type-1 | 0 | 0 | 0 | 1 |
Substance-K receptor | 0 | 4 | 0 | 4 |
D(1A) dopamine receptor | 0 | 6 | 0 | 7 |
D(4) dopamine receptor | 0 | 2 | 0 | 3 |
D(1B) dopamine receptor | 0 | 1 | 0 | 2 |
Adenylate cyclase type 3 | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 12 | 7 | 1 | 20 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 12 | 7 | 1 | 20 |
Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
Histamine H2 receptor | 0 | 8 | 0 | 8 |
Alpha-1D adrenergic receptor | 0 | 8 | 0 | 8 |
D(1B) dopamine receptor | 0 | 2 | 0 | 2 |
Proteasome subunit alpha type-1 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-2 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-4 | 0 | 0 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 4 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-8 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-9 | 0 | 0 | 0 | 1 |
Proteasome subunit alpha type-5 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-4 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-6 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 6 | 0 | 6 |
5-hydroxytryptamine receptor 2C | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 12 | 7 | 1 | 20 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 12 | 7 | 1 | 20 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
Trypanothione reductase | 0 | 4 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 12 | 7 | 1 | 20 |
D(4) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Histamine H1 receptor | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 2 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
Mu-type opioid receptor | 0 | 5 | 1 | 6 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 1 | 7 |
D(3) dopamine receptor | 0 | 6 | 0 | 7 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
Adenylate cyclase type 8 | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-10 | 0 | 0 | 0 | 1 |
Delta-type opioid receptor | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 8 | 0 | 8 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Histamine H2 receptor | 11 | 0 | 0 | 11 |
Proteasome subunit beta type-3 | 0 | 0 | 0 | 1 |
Proteasome subunit beta type-2 | 0 | 0 | 0 | 1 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Proteasome subunit alpha type-6 | 0 | 0 | 1 | 2 |
D(2) dopamine receptor | 0 | 2 | 0 | 3 |
Calmodulin | 0 | 1 | 2 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 12 | 7 | 1 | 20 |
Gamma-aminobutyric acid receptor subunit beta-2 | 12 | 7 | 2 | 21 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 5 | 0 | 6 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 5 | 1 | 7 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 5 | 0 | 7 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 3 | 0 | 3 |
Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
Adenylate cyclase type 6 | 0 | 2 | 0 | 2 |
Adenylate cyclase type 5 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 3 | 0 | 3 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 9 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 3 | 0 | 3 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 3 | 1 | 4 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 5 | 0 | 6 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 2 | 0 | 2 |
Proteasome subunit alpha-type 8 | 0 | 0 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 5 | 0 | 6 |
GABA theta subunit | 12 | 7 | 1 | 20 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Proteasome subunit beta type-7 | 0 | 0 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 2 | 2 | 4 |
Gamma-aminobutyric acid receptor subunit epsilon | 12 | 7 | 1 | 20 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 5 | 0 | 6 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 0 | 2 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 8 | 0 | 0 | 8 |
nuclear receptor ROR-gamma isoform 1 | 7 | 0 | 0 | 7 |
60 kDa chaperonin | 0 | 4 | 0 | 4 |
Vitamin D3 receptor | 0 | 1 | 1 | 4 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
cytochrome P450 2C9 precursor | 5 | 0 | 0 | 5 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 3 | 0 | 6 |
DNA gyrase subunit B | 0 | 3 | 0 | 6 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 3 | 0 | 6 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Cytochrome P450 2C19 | 0 | 2 | 1 | 3 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 3 | 0 | 4 |
DNA gyrase subunit A | 0 | 3 | 0 | 4 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
TAR DNA-binding protein 43 | 6 | 0 | 0 | 6 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Chymotrypsinogen A | 0 | 1 | 0 | 2 |
Amyloid-beta precursor protein | 1 | 5 | 0 | 6 |
Beta-lactamase | 0 | 0 | 0 | 3 |
Beta-galactosidase | 0 | 1 | 0 | 2 |
Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | 0 | 2 | 0 | 2 |
PH domain leucine-rich repeat-containing protein phosphatase 2 | 0 | 1 | 0 | 1 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
endonuclease IV | 4 | 0 | 0 | 4 |
peripheral myelin protein 22 isoform 1 | 8 | 0 | 0 | 8 |
atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 0 | 4 | 0 | 4 |
Lactoylglutathione lyase | 0 | 2 | 0 | 2 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 1 | 2 |
glp-1 receptor, partial | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 3 | 0 | 3 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-4 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 2 | 0 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 2 | 1 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 3 | 6 |
Translocator protein | 0 | 1 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 2 | 5 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 3 | 6 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 3 | 2 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 3 | 0 | 3 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 3 | 1 | 4 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 1 | 2 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 0 | 0 | 2 |
Thromboxane A2 receptor | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 3 | 2 | 5 |
Prostaglandin E2 receptor EP4 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 2 | 0 | 2 |
Prostaglandin F2-alpha receptor | 0 | 2 | 2 | 4 |
Prostaglandin E2 receptor EP3 subtype | 0 | 3 | 2 | 5 |
Prostaglandin E2 receptor EP2 subtype | 0 | 3 | 1 | 4 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostacyclin receptor | 0 | 3 | 1 | 4 |
Prostaglandin D2 receptor | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 2 | 0 | 5 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 2B1 | 0 | 1 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Eyes absent homolog 2 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 1 | 0 | 2 |
Beta-lactamase | 0 | 1 | 0 | 1 |
V-type proton ATPase subunit B, brain isoform | 0 | 1 | 0 | 1 |
RISC-loading complex subunit TARBP2 | 0 | 0 | 1 | 1 |
Motilin receptor | 0 | 0 | 1 | 1 |
low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
Motilin receptor | 0 | 1 | 1 | 2 |
Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Chitinase B | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
Genome polyprotein | 0 | 1 | 1 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 2 | 0 | 0 | 2 |
thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
bromodomain adjacent to zinc finger domain 2B | 5 | 0 | 0 | 5 |
thyrotropin-releasing hormone receptor | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 6 | 0 | 0 | 6 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
large T antigen | 0 | 1 | 0 | 1 |
Chain A, Uracil Phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Skn7p | 0 | 0 | 0 | 1 |
nonstructural protein 1 | 4 | 0 | 0 | 4 |
hemoglobin subunit beta | 1 | 0 | 0 | 1 |
huntingtin isoform 2 | 3 | 0 | 0 | 3 |
Vpr | 2 | 0 | 0 | 2 |
muscleblind-like protein 1 isoform 1 | 5 | 0 | 0 | 5 |
Thymidylate synthase | 0 | 1 | 0 | 2 |
Aromatase | 0 | 3 | 0 | 3 |
HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
Menin | 0 | 0 | 1 | 1 |
Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
Lethal factor | 0 | 1 | 0 | 1 |
Protein Rev | 0 | 0 | 1 | 1 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
transcriptional regulator ERG isoform 3 | 2 | 0 | 0 | 2 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent taurine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 3 |
Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 6 | 0 | 0 | 6 |
alpha synuclein, partial | 1 | 0 | 0 | 1 |
luciferase | 1 | 0 | 0 | 1 |
tumor necrosis factor | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 1 | 0 | 0 | 1 |
Androgen receptor | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 4 | 0 | 4 |
Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 1 | 1 | 0 | 2 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
Chain A, HISTIDINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Carbonic anhydrase 12 | 0 | 4 | 0 | 5 |
Plasma kallikrein | 0 | 0 | 0 | 1 |
Carbonic anhydrase 3 | 0 | 4 | 0 | 5 |
Histidine-binding periplasmic protein | 0 | 0 | 1 | 1 |
Carbonic anhydrase 4 | 0 | 6 | 0 | 7 |
Carbonic anhydrase 6 | 0 | 5 | 0 | 6 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Carbonic anhydrase 5A, mitochondrial | 0 | 6 | 0 | 8 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase 7 | 0 | 4 | 0 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 2 | 0 | 2 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 6 | 0 | 7 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 2 |
Carbonic anhydrase 15 | 0 | 5 | 0 | 6 |
Carbonic anhydrase 13 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 14 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 5B, mitochondrial | 0 | 4 | 0 | 6 |
alpha-galactosidase | 3 | 0 | 0 | 3 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Beta-lactamase TEM | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
Beta-lactamase IMP-1 | 0 | 0 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 2 |
7,8-dihydro-8-oxoguanine triphosphatase | 0 | 1 | 0 | 1 |
Toll-like receptor 8 | 0 | 0 | 1 | 1 |
Toll-like receptor 7 | 0 | 0 | 1 | 1 |
Chain A, meta-Cleavage product hydrolase | 0 | 1 | 0 | 1 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Parkin | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
Ornithine decarboxylase | 0 | 0 | 0 | 2 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 4 |
Retinoic acid receptor beta | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 1 | 0 | 3 | 0 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Cellular retinoic acid-binding protein 1 | 0 | 2 | 0 | 3 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 2 | 2 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
ClpP | 1 | 0 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 1 | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 3 | 0 | 3 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 3 |
Kappa-type opioid receptor | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 1 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
GALC protein | 3 | 0 | 0 | 3 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
Chain B, Exotoxin A | 0 | 0 | 1 | 1 |
STE24 | 0 | 0 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
Trypsin | 0 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
Valosin-containing protein | 0 | 1 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 1 | 0 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 1 | 0 | 1 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
cytochrome P450 2C19 precursor | 3 | 0 | 0 | 3 |
Chain A, Immunoglobulin | 0 | 0 | 1 | 1 |
Chain B, Immunoglobulin | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M4 | 0 | 0 | 1 | 2 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M5 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M3 | 0 | 0 | 1 | 2 |
Muscarinic acetylcholine receptor M2 | 0 | 0 | 1 | 2 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Albumin | 0 | 0 | 1 | 1 |
Neutrophil elastase | 0 | 1 | 0 | 1 |
Complement C1s subcomponent | 0 | 1 | 0 | 1 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 2 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Collagenase 3 | 0 | 2 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 1 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 1 | 0 | 2 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
Chain A, PUTRESCINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | 0 | 1 | 0 | 1 |
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | 0 | 1 | 0 | 1 |
Chain A, S-ADENOSYLMETHIONINE DECARBOXYLASE ALPHA CHAIN | 0 | 1 | 0 | 1 |
Chain B, S-ADENOSYLMETHIONINE DECARBOXYLASE BETA CHAIN | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 3 | 0 | 3 |
S-adenosylmethionine decarboxylase proenzyme | 0 | 0 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 3 | 0 | 3 |
Monocarboxylate transporter 4 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 0 | 0 | 1 |
C-terminal-binding protein 2 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
Chain A, PLASMA RETINOL-BINDING PROTEIN PRECURSOR | 0 | 0 | 1 | 1 |
Retinol-binding protein 4 | 0 | 0 | 1 | 1 |
Beta-lactoglobulin | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 2 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Polymerase acidic protein | 0 | 0 | 1 | 1 |
Stromelysin-1 | 0 | 1 | 1 | 2 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
High mobility group protein B1 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 3 |
Estrogen receptor | 0 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
PPM1D protein | 1 | 0 | 0 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Sulfate anion transporter 1 | 0 | 0 | 0 | 1 |
Caspase-2 | 0 | 0 | 1 | 1 |
Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Chain A, Acetylcholinesterase | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Delta-type opioid receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Protein argonaute-2 | 0 | 0 | 1 | 1 |
Prostaglandin E synthase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B10 | 0 | 1 | 0 | 1 |
Complement C5 | 0 | 0 | 1 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-alpha | 0 | 3 | 2 | 5 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 2 | 2 |
Endothelin-1 receptor | 0 | 2 | 0 | 2 |
90-kda heat shock protein beta HSP90 beta, partial | 0 | 1 | 0 | 1 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
tyrosine-protein phosphatase non-receptor type 7 isoform 2 | 0 | 1 | 0 | 1 |
Tetracycline resistance protein, class B | 0 | 0 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Multidrug transporter MdfA | 0 | 1 | 0 | 1 |
Neutrophil collagenase | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 2 | 1 | 3 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |